최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기精神身體醫學 = Korean journal of psychosomatic medicine, v.26 no.2, 2018년, pp.77 - 85
이상신 (고신대학교 의과대학 정신의학교실) , 임효덕 (경북대학교 의과대학 정신의학교실) , 우정민 (경북대학교 의과대학 정신의학교실)
Objectives : This study aimed to investigate the level of distress using the distress thermometer (DT) and the factors associated with distress in postoperative breast cancer (BC) patients. Methods : DT and WHOQOL-BREF (World Health Organization Quality of Life Scale Abbreviated Version) along with ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
유방암 수술로 인해 발생하는 문제점은 무엇인가? | 6,7) 그러나 권고안 및 널리 알려진 이론적 중요성에도 불구하고 이러한 디스트레스 관리 지침이 준수되고 있지 않은 것이 현실이다.8) 유방암 수술은 대표적인 치료 방법 중 하나이지만 유방 변형, 절단과 같은 신체상(body image) 손상과 이에 따른 우울, 불안, 삶의 질 저하와 연관되기도 한다.9) 유방암 수술을 받는 환자의 약 80%가 수술 전 3개월이내에 진단을 받았다는 점과,10) 유방암 수술을 받은 환자가 어떤 방식으로든 심리적 적응을 하는데 약 6개월 이상이 소요된다는 점을 고려하면11) 수술을 받는 유방암 환자들은 암 진단이라는 충격과 불확실성에서 아직 빠져나오지 못한 상태일 가능성이 높다. | |
유방암 환자의 디스트레스와 연관된 요인에 따른 결과가 일정하지 않은 이유는 무엇인가? | 유방암 환자의 디스트레스와 연관된 요인으로 사회인구학적, 암 및 암 치료 관련, 신체 및 생리기능, 심리 및 성격 관련 요인 등의 다양한 측면이 보고되어 왔으나16-22) 아직 일관된 결과를 보이고 있지 않다. 그 이유는 대상자의 암 상태, 암 치료 단계, 디스트레스 측정도구 등이 연구마다 다르다는 점도 있지만,19) 디스트레스 자체가 심리, 사회, 영적, 신체적 등의 다양한 측면이 있기 때문이기도 할 것이다.23)암 환자를 대상으로 하는 연구에서 자주 사용되는 World Health Oorganization Quality Of Life scale (WHOQOL), European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30), Functional Assessment of Cancer Therapy–Breast (FACT-B)와 같은 삶의 질 척도는 신체, 심리 등의 포괄적인 영역이 포함되어 있다. | |
디스트레스는 무엇인가? | ‘디스트레스(Distress)’는 암, 암의 신체 증상 및 치료에 효과적으로 대처하는 것을 방해할 수 있는 심리적, 사회적, 영적 혹은 신체적 경험으로 정의된다. 디스트레스에는 취약한 느낌, 슬픔 등의 정상 감정에서부터 우울, 불안, 공황, 사회적 고립 그리고 실존적 혹은 영적 위기에 이르기까지 다양한 감정이 포함된다. |
NCCN org [homepage on the Internet]. Fort Washington: National Comprehensive Cancer Network. NCCN Guidelines for Distress Management version 2.2018-February 23,2018 [cited 2018 Jun 21]. Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#supportive.
Hershman DL, Kushi LH, Hillyer GC, Coromilas E, Buono D, Lamerato L, Bovbjerg DH, Mandelblatt JS, Tsai WY, Zhong X, Jacobson JS, Wright JD, Neugut AI. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat 2016; 157:133-143.
Brunault P, Champagne A-, Huguet G, Suzanne I, Senon JL, Body G, Rusch E, Magnin G, Voyer M, Reveillere C, Camus V. Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology 2016;25:513-520.
Andersen BL, Yang HC, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton LM, Young DC, Carson WE 3rd. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008;113:3450-3458.
Eskelinen M, Korhonen R, Selander T, Ollonen P. Beck Depression Inventory as a Predictor of Long-term Outcome Among Patients Admitted to the Breast Cancer Diagnosis Unit: A 25-year Cohort Study in Finland. Anticancer Res 2017; 37:819-824.
Yu ES, Shim EJ, Kim HK, Hahm BJ, Park JH, Kim JH. Development of guidelines for distress management in Korean cancer patients. Psychooncology 2012;21:541-549.
Cancer.go.kr [homepage on the Internet]. GyeongGi-Do: National Cancer Information Center. Recommendations for Distress Management in Cancer Patients [updated 2010 Jun 4;cited 2018 June 21]. Available from: https://www.cancer.go.kr/lay1/bbs/S1T674C680/B/26/view.do?article_seq19644.
Kang JI, Sung NY, Park SJ, Lee CG, Lee BO. The epidemiology of psychiatric disorders among women with breast cancer in South Korea: analysis of national registry data. Psychooncology 2014;23:35-39.
Begovic-Juhant A, Chmielewski A, Iwuagwu S, Chapman LA. Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol 2012;30: 446-460.
Kim JY, Woo J, Lee SS, Kim HW, Khang D, Rim HD. Psychological factors predicting delayed diagnosis of breast cancer: the role of marital relationship functioning. Korean J Psychosom Med 2014;22:13-22.
Lam WW, Bonanno GA, Mancini AD, Ho S, Chan M, Hung WK, Or A, Fielding R. Trajectories of psychological distress among Chinese women diagnosed with breast cancer. Psychooncology 2010;19:1044-1051.
Liu JE, Wang HY, Wang ML, Su YL, Wang PL. Posttraumatic growth and psychological distress in Chinese early-stage breast cancer survivors: a longitudinal study. Psychooncology 2014;23:437-443.
Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 2010;45:355-361.
Saboonchi F, Petersson LM, Wennman-Larsen A, Alexanderson K, Brannstrom R, Vaez M. Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response. Eur J Oncol Nurs 2014;18:598-604.
Lam WW, Shing YT, Bonanno GA, Mancini AD, Fielding R. Distress trajectories at the first year diagnosis of breast cancer in relation to 6 years survivorship. Psychooncology 2012; 21:90-99.
Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN, Tamblyn R. Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 2017;165:229-245.
Brandao T, Schulz MS, Matos PM. Psychological adjustment after breast cancer: a systematic review of longitudinal studies. Psychooncology 2017;26:917-926.
Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005;330: 702-705.
Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K, Pierce JP. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 2006; 24:2420-2427.
Tojal C, Costa R. Depressive symptoms and mental adjustment in women with breast cancer. Psycho-Oncology 2015;24: 1060-1065.
Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM, START Trials Management Group. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast 2010;19:84-91.
Jorgensen L, Laursen BS, Garne JP, Sherman KA, Sogaard M. Prevalence and predictors of distress in women taking part in surgical continuity of care for breast cancer: A cohort study. Eur J Oncol Nurs 2016;22:30-36.
Mitchell AJ. Screening and assessment for distress. Holland JC, Breitbart W, Butow P, Jacobsen PB, Loscalzo M, Mc-Corkle R, editors. Psycho-oncology, 3rd ed. New York: Oxford University Press;2015. p.384-395.
Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol 2009;99:447-455.
Paraskevi T. Quality of life outcomes in patients with breast cancer. Oncol Rev 2012;6:e2.
Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007;25: 4670-4681.
Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, Zhou M, Sang Y, Jiang Y, Liu L. The diagnostic role of a short screening tool--the distress thermometer: a meta-analysis. Support Care Cancer 2014;22:1741-1755.
Min SK, Kim KI, Park IH. Korean version of WHOQO. Seoul: Hana Medical Publishing;2002. p.7-70.
Agarwal J, Powers K, Pappas L, Buchmann L, Anderson L, Gauchay L, Rich A. Correlates of elevated distress thermometer scores in breast cancer patients. Support Care Cancer 2013;21:2125-2136.
Bidstrup PE, Johansen C, Mitchell AJ. Screening for cancer-related distress: Summary of evidence from tools to programmes. Acta Oncol 2011;50:194-204.
Mertz BG, Bistrup PE, Johansen C, Dalton SO, Deltour I, Kehlet H, Kroman N. Psychological distress among women with newly diagnosed breast cancer. Eur J Oncol Nurs 2012; 16:439-443.
Hegel MT, Collins ED, Kearing S, Gillock KL, Moore CP, Ahles TA. Sensitivity and specificity of the Distress Thermometer for depression in newly diagnosed breast cancer patients. Psychooncology 2008;17:556-560.
Ho SY, Rohan KJ, Parent J, Tager FA, McKinley PS. A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. J Pain Symptom Manage 2015;49:707-715.
Khang D, Rim HD, Woo J. The korean version of the body image scale-reliability and validity in a sample of breast cancer patients. Psychiatry Investig 2013;10:26-33.
Roma S, Tickoo R, Garrett Key, Willian S. Breitbart. Cancer-related pain Holland JC, Breitbart W, Butow P, Jacobsen PB, Loscalzo M, McCorkle R, editors. Psycho-oncology, 3rd ed. New York: Oxford University Press;2015. p.171-198.
Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F, ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23 Suppl 7:vii139-154.
Savard J, Savard MH. Insomnia and cancer: Prevalence, nature, and nonpharmacologic treatment. Sleep Med Clin 2013;8: 373-387.
Savard J, Ivers H, Savard MH, Morin CM. Cancer treatments and their side effects are associated with aggravation of insomnia: Results of a longitudinal study. Cancer 2015;121: 1703-1711.
Caplette-Gingras A, Savard J, Savard MH, Ivers H. Is Insomnia Associated With Cognitive Impairments in Breast Cancer Patients? Behav Sleep Med 2013;11:239-257.
Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol 2009;27:5233-5239.
Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T. Sleeping well with cancer: A systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat 2014;10:1113-1123.
Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 2004;91:822-828.
Tomlinson D, Robinson PD, Oberoi S, Cataudella D, Culos-Reed N, Davis H, Duong N, Gibson F, Gotte M, Hinds P, Nijhof SL, van der Torre P, Cabral S, Dupuis LL, Sung L. Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. Curr Oncol 2018;25:e152-e167.
Qu D, Zhang Z, Yu X, Zhao J, Qiu F, Huang J. Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis. Eur J Cancer Care 2016;25: 970-979.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.